Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching hundreds of dollars per prescription. The poll found that about half of Americans support Medicare and Medicaid covering weight-loss drugs for those with obesity, while around 20 percent oppose it and 25 percent are neutral.
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily used for managing type 2 diabetes, whereas Wegovy is specifically approved for weight loss.
The National Pharmacy Association has written to regulators calling for tougher rules following reports that some online sellers have set targets for clinicians to process more than 20 patients every ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Weight loss injections are prescription medications to help with weight loss. They can help alter a person’s appetite and metabolism, curbing hunger and reducing calorie intake. Weight ...
Weight loss medications and injections have become very popular in the past two years, but they must be used in conjunction ...
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...
The National Pharmacy Association is calling for tougher rules in the market, saying people with a history of eating ...
If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback